Max Healthcare reported an 85% YoY increase in net profit to INR320 crore in Q4FY23, supported by better operating metrics and lower finance costs. The healthcare chain’s gross revenue rose 26% to INR1,637 crore compared to the corresponding period of the previous year. The EBITDA margin also improved 310 basis points YoY to 28.2%. The addition of a new 92-bed oncology block in March 2023 at the Max Shalimar Bagh hospital has increased the hospital’s capacity to 3,500 beds. Meanwhile, Max Healthcare board has recommended a dividend of INR1 per share.
Subscribe To Our Free Newsletter |